These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29727215)

  • 21. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
    Decaluwé K; Pauwels B; Boydens C; Thoonen R; Buys ES; Brouckaert P; Van de Voorde J
    J Sex Med; 2017 Feb; 14(2):196-204. PubMed ID: 28161078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fraction.
    Wilck N; Markó L; Balogh A; Kräker K; Herse F; Bartolomaeus H; Szijártó IA; Gollasch M; Reichhart N; Strauss O; Heuser A; Brockschnieder D; Kretschmer A; Lesche R; Sohler F; Stasch JP; Sandner P; Luft FC; Müller DN; Dechend R; Haase N
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble guanylate cyclase stimulator praliciguat attenuates inflammation, fibrosis, and end-organ damage in the Dahl model of cardiorenal failure.
    Shea CM; Price GM; Liu G; Sarno R; Buys ES; Currie MG; Masferrer JL
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F148-F159. PubMed ID: 31608671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
    Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodeling.
    Hutchinson KR; Saripalli C; Chung CS; Granzier H
    J Mol Cell Cardiol; 2015 Feb; 79():104-14. PubMed ID: 25450617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease.
    Tobin JV; Zimmer DP; Shea C; Germano P; Bernier SG; Liu G; Long K; Miyashiro J; Ranganath S; Jacobson S; Tang K; Im GJ; Sheppeck J; Moore JD; Sykes K; Wakefield J; Sarno R; Banijamali AR; Profy AT; Milne GT; Currie MG; Masferrer JL
    J Pharmacol Exp Ther; 2018 Jun; 365(3):664-675. PubMed ID: 29643251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1.
    Hopf AE; Andresen C; Kötter S; Isić M; Ulrich K; Sahin S; Bongardt S; Röll W; Drove F; Scheerer N; Vandekerckhove L; De Keulenaer GW; Hamdani N; Linke WA; Krüger M
    Circ Res; 2018 Jul; 123(3):342-355. PubMed ID: 29760016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.
    Methawasin M; Strom JG; Slater RE; Fernandez V; Saripalli C; Granzier H
    Circulation; 2016 Oct; 134(15):1085-1099. PubMed ID: 27630136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
    Zhang N; Feng B; Ma X; Sun K; Xu G; Zhou Y
    Cardiovasc Diabetol; 2019 Aug; 18(1):107. PubMed ID: 31429767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.
    Hamdani N; Bishu KG; von Frieling-Salewsky M; Redfield MM; Linke WA
    Cardiovasc Res; 2013 Mar; 97(3):464-71. PubMed ID: 23213108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained soluble guanylate cyclase stimulation offsets nitric-oxide synthase inhibition to restore acute cardiac modulation by sildenafil.
    Nagayama T; Zhang M; Hsu S; Takimoto E; Kass DA
    J Pharmacol Exp Ther; 2008 Aug; 326(2):380-7. PubMed ID: 18456872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure.
    Triposkiadis F; Xanthopoulos A; Skoularigis J; Starling RC
    Heart Fail Rev; 2022 Nov; 27(6):1991-2003. PubMed ID: 35437713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
    Lundgren J; Kylhammar D; Hedelin P; Rådegran G
    Acta Physiol (Oxf); 2012 Nov; 206(3):178-94. PubMed ID: 22682645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
    Breitenstein S; Roessig L; Sandner P; Lewis KS
    Handb Exp Pharmacol; 2017; 243():225-247. PubMed ID: 27900610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic effects of soluble guanylate cyclase stimulation on pulmonary hemodynamics and emphysema development in guinea pigs chronically exposed to cigarette smoke.
    Paul T; Blanco I; Aguilar D; Tura-Ceide O; Bonjoch C; Smolders VF; Peinado VI; Barberà JA
    Am J Physiol Lung Cell Mol Physiol; 2019 Aug; 317(2):L222-L234. PubMed ID: 31166128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?
    Koress C; Swan K; Kadowitz P
    Curr Hypertens Rep; 2016 Apr; 18(5):42. PubMed ID: 27118316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble Guanylate Cyclase-Mediated Relaxation in Aortas from Rats with Renovascular Hypertension.
    Tawa M; Shimosato T; Nakagawa K; Okamura T; Ohkita M
    Pharmacology; 2022; 107(3-4):235-240. PubMed ID: 34929695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system.
    Correia SS; Liu G; Jacobson S; Bernier SG; Tobin JV; Schwartzkopf CD; Atwater E; Lonie E; Rivers S; Carvalho A; Germano P; Tang K; Iyengar RR; Currie MG; Hadcock JR; Winrow CJ; Jones JE
    J Neuroinflammation; 2021 Sep; 18(1):213. PubMed ID: 34537066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial.
    Armstrong PW; Roessig L; Patel MJ; Anstrom KJ; Butler J; Voors AA; Lam CSP; Ponikowski P; Temple T; Pieske B; Ezekowitz J; Hernandez AF; Koglin J; O'Connor CM
    JACC Heart Fail; 2018 Feb; 6(2):96-104. PubMed ID: 29032136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.